<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medipan &amp; GA Generic Assays</title>
	<atom:link href="https://www.medipan.de/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.medipan.de/</link>
	<description>Your reliable partner in autoimmune diagnostics</description>
	<lastBuildDate>Mon, 13 Apr 2026 11:54:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.medipan.de/wp-content/uploads/2025/03/cropped-favicon-2-512x512-1-32x32.png</url>
	<title>Medipan &amp; GA Generic Assays</title>
	<link>https://www.medipan.de/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2026-04 /Medipan &#038; GA Generic Assays at the BDRh Congress 2026 in Berlin</title>
		<link>https://www.medipan.de/2026-02-medipan-at-the-bdrh-congress-2026/</link>
		
		<dc:creator><![CDATA[Augustina Bertram]]></dc:creator>
		<pubDate>Mon, 13 Apr 2026 08:27:00 +0000</pubDate>
				<category><![CDATA[Upcoming]]></category>
		<category><![CDATA[Events]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=106353</guid>

					<description><![CDATA[<p> <img width="300" height="163" src="https://www.medipan.de/wp-content/uploads/2026/02/BDRheng-e1770902953874-300x163.png" class="attachment-medium size-medium wp-post-image" alt="Promotional banner for the 21st Congress of the Professional Association of German Rheumatologists (BDRh), taking place April 24–25, 2026, at the Estrel Berlin. The red and orange design features the BDRh and Medipan/Generic Assays logos, the motto &quot;Sharing knowledge - securing the future,&quot; and a circular photo of the Estrel Hotel." decoding="async" srcset="https://www.medipan.de/wp-content/uploads/2026/02/BDRheng-e1770902953874-300x163.png 300w, https://www.medipan.de/wp-content/uploads/2026/02/BDRheng-e1770902953874-1024x555.png 1024w, https://www.medipan.de/wp-content/uploads/2026/02/BDRheng-e1770902953874-768x416.png 768w, https://www.medipan.de/wp-content/uploads/2026/02/BDRheng-e1770902953874.png 1366w" sizes="(max-width: 300px) 100vw, 300px" /> April 24–25, 2026 &#124; 21st Annual Congress of the German Rheumatologists Association (BDRh)&#124; Estrel Berlin On April 24 and 25, 2026, the 21st Annual Congress of the German Rheumatologists Association (BDRh) will take place for the first time at Estrel Berlin. Under the motto “Sharing Knowledge – Securing the Future”, the congress brings together rheumatologists, [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/2026-02-medipan-at-the-bdrh-congress-2026/">2026-04 /Medipan &amp; GA Generic Assays at the BDRh Congress 2026 in Berlin</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>2026-05/ 11th Dresden Liquor Symposium</title>
		<link>https://www.medipan.de/11th-dresden-liquor-symposium/</link>
		
		<dc:creator><![CDATA[Augustina Bertram]]></dc:creator>
		<pubDate>Thu, 02 Apr 2026 12:28:00 +0000</pubDate>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[Upcoming]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=106402</guid>

					<description><![CDATA[<p> <img width="300" height="161" src="https://www.medipan.de/wp-content/uploads/2026/02/11th-Dresden-Liquor-Symposium-e1771326950104-300x161.png" class="attachment-medium size-medium wp-post-image" alt="Banner for the 11th Dresden Liquor Symposium, taking place on May 9, 2026. The central image shows a laboratory result for &quot;CSF Isofocusing&quot; (Cerebrospinal Fluid analysis) with blue-stained protein bands on a gel. The banner features the logos of labopart, Medipan, and GA Generic Assays." decoding="async" srcset="https://www.medipan.de/wp-content/uploads/2026/02/11th-Dresden-Liquor-Symposium-e1771326950104-300x161.png 300w, https://www.medipan.de/wp-content/uploads/2026/02/11th-Dresden-Liquor-Symposium-e1771326950104-1024x551.png 1024w, https://www.medipan.de/wp-content/uploads/2026/02/11th-Dresden-Liquor-Symposium-e1771326950104-768x413.png 768w, https://www.medipan.de/wp-content/uploads/2026/02/11th-Dresden-Liquor-Symposium-e1771326950104.png 1366w" sizes="(max-width: 300px) 100vw, 300px" /> May 09th 2026 &#124; Dorint Hotel Dresden &#124; Dresden, Germany Exciting Updates from the 11th Dresden Liquor Symposium On May 9, 2026, leading experts from across Germany and beyond will gather at the Dorint Hotel Dresden for the 11th Dresden Liquor Symposium, an important events for the latest developments in cerebrospinal fluid (CSF) diagnostics. The [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/11th-dresden-liquor-symposium/">2026-05/ 11th Dresden Liquor Symposium</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>2026-05 /Medipan &#038; GA Generic Assays at the 15th Autoimmunity Congress</title>
		<link>https://www.medipan.de/2026-05-medipan-ga-generic-assays-at-the-15th-autoimmunity-congress/</link>
		
		<dc:creator><![CDATA[Augustina Bertram]]></dc:creator>
		<pubDate>Mon, 23 Mar 2026 11:44:09 +0000</pubDate>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[Upcoming]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=106377</guid>

					<description><![CDATA[<p> <img width="300" height="168" src="https://www.medipan.de/wp-content/uploads/2026/02/Design-ohne-Titel-1-300x168.png" class="attachment-medium size-medium wp-post-image" alt="Official event banner for the 15th International Congress on Autoimmunity 2026. The graphic combines purple branding elements with a panoramic photograph of Prague&#039;s Old Town and St. Vitus Cathedral." decoding="async" fetchpriority="high" srcset="https://www.medipan.de/wp-content/uploads/2026/02/Design-ohne-Titel-1-300x168.png 300w, https://www.medipan.de/wp-content/uploads/2026/02/Design-ohne-Titel-1.png 768w" sizes="(max-width: 300px) 100vw, 300px" /> May 14 &#8211; 17, 2026 &#124; Prague Congress Centre &#124; Prague, Czech Republic Join Us at the 15th International Congress on Autoimmunity in Prague We are excited to announce that Medipan GmbH &#38; GA Generic Assays GmbH will be participating in the 15th International Congress on Autoimmunity, taking place from May 14-17, 2026, in Prague, [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/2026-05-medipan-ga-generic-assays-at-the-15th-autoimmunity-congress/">2026-05 /Medipan &amp; GA Generic Assays at the 15th Autoimmunity Congress</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Serological Biomarkers in Primary Sclerosing Cholangitis (PSC): Focus on anti-GP2 IgA</title>
		<link>https://www.medipan.de/serological-biomarkers-in-psc-focus-on-anti-gp2-iga/</link>
		
		<dc:creator><![CDATA[Dr. Stefano Frasca]]></dc:creator>
		<pubDate>Fri, 20 Mar 2026 07:34:26 +0000</pubDate>
				<category><![CDATA[Product News]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=107421</guid>

					<description><![CDATA[<p> <img width="300" height="158" src="https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_1248714755-scaled-e1773989015794-300x158.jpeg" class="attachment-medium size-medium wp-post-image" alt="Anfrage erfolgreich Gemini hat gesagt This image features a medical doctor, explaining human anatomy using a detailed anatomical model of the liver and gallbladder." decoding="async" loading="lazy" srcset="https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_1248714755-scaled-e1773989015794-300x158.jpeg 300w, https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_1248714755-scaled-e1773989015794-1024x538.jpeg 1024w, https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_1248714755-scaled-e1773989015794-768x403.jpeg 768w, https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_1248714755-scaled-e1773989015794-1536x806.jpeg 1536w, https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_1248714755-scaled-e1773989015794-2048x1075.jpeg 2048w" sizes="auto, (max-width: 300px) 100vw, 300px" /> Primary sclerosing cholangitis (PSC) is a chronic, progressive inflammatory disease affecting the bile ducts and often leading to fibrosis, cirrhosis, and eventually liver failure. PSC also carries an increased risk of hepatobiliary malignancies, particularly cholangiocarcinoma. Despite significant research efforts, PSC remains difficult to diagnose and manage because its pathogenesis is not fully understood and reliable [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/serological-biomarkers-in-psc-focus-on-anti-gp2-iga/">Serological Biomarkers in Primary Sclerosing Cholangitis (PSC): Focus on anti-GP2 IgA</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Variability in Diagnostic Test Results</title>
		<link>https://www.medipan.de/variability-in-diagnostic-test-results/</link>
		
		<dc:creator><![CDATA[Augustina Bertram]]></dc:creator>
		<pubDate>Tue, 10 Mar 2026 13:32:12 +0000</pubDate>
				<category><![CDATA[All News]]></category>
		<category><![CDATA[Product News]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=107256</guid>

					<description><![CDATA[<p> <img width="300" height="178" src="https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_685703621-scaled-e1773152071145-300x178.jpeg" class="attachment-medium size-medium wp-post-image" alt="Two female scientists work in a modern equipped computer laboratory analyzing blood samples and genetic materials using special machines in a modern laboratory." decoding="async" loading="lazy" srcset="https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_685703621-scaled-e1773152071145-300x178.jpeg 300w, https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_685703621-scaled-e1773152071145-1024x609.jpeg 1024w, https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_685703621-scaled-e1773152071145-768x457.jpeg 768w, https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_685703621-scaled-e1773152071145-1536x914.jpeg 1536w, https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_685703621-scaled-e1773152071145-2048x1218.jpeg 2048w" sizes="auto, (max-width: 300px) 100vw, 300px" /> Understanding Normal Analytical Variation In diagnostic testing, it is not uncommon to observe small differences when the same sample is measured repeatedly. Such variations are expected and reflect the inherent characteristics of the assay, even under well-controlled laboratory conditions. Diagnostic assays rely on complex biological, chemical, and technical processes. Each step introduces a degree of [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/variability-in-diagnostic-test-results/">Variability in Diagnostic Test Results</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		<enclosure url="https://www.medipan.de/wp-content/uploads/2026/03/AdobeStock_366259336.mp4" length="1506974" type="video/mp4" />

			</item>
		<item>
		<title>AI-Based ANA HEp-2 IFA Interpretation: Clinical Validation in Routine Diagnostics</title>
		<link>https://www.medipan.de/ai-based-ana-hep-2-ifa-interpretation-clinical-validation-in-routine-diagnostics/</link>
		
		<dc:creator><![CDATA[Dr. Stefano Frasca]]></dc:creator>
		<pubDate>Wed, 25 Feb 2026 09:01:37 +0000</pubDate>
				<category><![CDATA[Product News]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=106503</guid>

					<description><![CDATA[<p> <img width="300" height="159" src="https://www.medipan.de/wp-content/uploads/2026/02/akironNEOinlab-e1772002787969-300x159.png" class="attachment-medium size-medium wp-post-image" alt="A modern laboratory setting featuring two scientists in the background wearing white lab coats and looking at a tablet. In the foreground sits the &quot;akiron® NEO&quot; analyzer with an integrated screen displaying an immunofluorescence image (bright green dots on a black background). Pipettes, a barcode scanner, and a microscope are also visible on the lab bench." decoding="async" loading="lazy" srcset="https://www.medipan.de/wp-content/uploads/2026/02/akironNEOinlab-e1772002787969-300x159.png 300w, https://www.medipan.de/wp-content/uploads/2026/02/akironNEOinlab-e1772002787969-1024x541.png 1024w, https://www.medipan.de/wp-content/uploads/2026/02/akironNEOinlab-e1772002787969-768x406.png 768w, https://www.medipan.de/wp-content/uploads/2026/02/akironNEOinlab-e1772002787969.png 1184w" sizes="auto, (max-width: 300px) 100vw, 300px" /> Antinuclear antibody (ANA) testing by indirect immunofluorescence assay (IFA) on HEp-2 cells remains the gold standard screening method for systemic autoimmune rheumatic diseases (SARD), including systemic lupus erythematosus, systemic sclerosis and Sjögren’s syndrome. However, manual interpretation of ANA HEp-2 IFA patterns is time-consuming, operator-dependent and subject to inter-observer variability. A recent large-scale study published in [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/ai-based-ana-hep-2-ifa-interpretation-clinical-validation-in-routine-diagnostics/">AI-Based ANA HEp-2 IFA Interpretation: Clinical Validation in Routine Diagnostics</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Celebrating 8 Years of Excellence in the CAP Antinuclear Antibody (ANA) Survey!</title>
		<link>https://www.medipan.de/celebrating-cap-antinuclear-ntibody-ana-survey/</link>
		
		<dc:creator><![CDATA[Dr. Stefano Frasca]]></dc:creator>
		<pubDate>Fri, 20 Feb 2026 14:10:00 +0000</pubDate>
				<category><![CDATA[Product News]]></category>
		<category><![CDATA[CAP]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=9799</guid>

					<description><![CDATA[<p> <img width="300" height="169" src="https://www.medipan.de/wp-content/uploads/2024/02/CAoAP-300x169.png" class="attachment-medium size-medium wp-post-image" alt="A &quot;Certificate of Participation&quot; from the College of American Pathologists (CAP) issued to Medipan GmbH. The certificate recognizes participation in proficiency testing or anatomic pathology education programs for the 2025 program year. It includes CAP number 8110610-01 and signatures from Bobbi S. Pritt and Donald S. Karcher. The Medipan logo is displayed in the top right corner." decoding="async" loading="lazy" srcset="https://www.medipan.de/wp-content/uploads/2024/02/CAoAP-300x169.png 300w, https://www.medipan.de/wp-content/uploads/2024/02/CAoAP-1024x576.png 1024w, https://www.medipan.de/wp-content/uploads/2024/02/CAoAP.png 1366w" sizes="auto, (max-width: 300px) 100vw, 300px" /> Celebrating 8 Years of Excellence in the CAP Antinuclear Antibody (ANA) Survey! We are proud to announce an important milestone in our quality journey: Eight consecutive years of successful participation in the Antinuclear Antibody (ANA) Survey organized by the College of American Pathologists (CAP). Eight Years of Commitment to Quality For eight years, our laboratory [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/celebrating-cap-antinuclear-ntibody-ana-survey/">Celebrating 8 Years of Excellence in the CAP Antinuclear Antibody (ANA) Survey!</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Anti–Factor H Autoantibodies and ELISA Testing: Optimizing Diagnosis in Atypical Hemolytic Uremic Syndrome (aHUS)</title>
		<link>https://www.medipan.de/anti-factor-h-autoantibodies-and-elisa-testing-optimizing-diagnosis-in-atypical-hemolytic-uremic-syndrome-ahus/</link>
		
		<dc:creator><![CDATA[Dr. Stefano Frasca]]></dc:creator>
		<pubDate>Mon, 02 Feb 2026 07:21:14 +0000</pubDate>
				<category><![CDATA[Product News]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=106041</guid>

					<description><![CDATA[<p> <img width="300" height="200" src="https://www.medipan.de/wp-content/uploads/2023/10/MTP-Labrorant_AdobeStock_299915758-1-300x200.jpeg" class="attachment-medium size-medium wp-post-image" alt="This is a close-up shot of a scientist or lab technician at work. The person, wearing a white lab coat and blue disposable gloves, is holding a 96-well microplate containing a blue liquid. With their other hand, they are using a micropipette to carefully dispense a sample into one of the wells, suggesting a scientific experiment or analysis is in progress." decoding="async" loading="lazy" srcset="https://www.medipan.de/wp-content/uploads/2023/10/MTP-Labrorant_AdobeStock_299915758-1-300x200.jpeg 300w, https://www.medipan.de/wp-content/uploads/2023/10/MTP-Labrorant_AdobeStock_299915758-1-1024x683.jpeg 1024w" sizes="auto, (max-width: 300px) 100vw, 300px" /> Atypical hemolytic uremic syndrome (aHUS), also known as complement-mediated thrombotic microangiopathy (CM-TMA), is a rare but life-threatening condition caused by dysregulation of the alternative complement pathway. Among the known etiologies, autoantibodies against complement factor H (anti-factor H) play a critical role, accounting for approximately 10% of cases. Accurate laboratory detection of these antibodies is essential, [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/anti-factor-h-autoantibodies-and-elisa-testing-optimizing-diagnosis-in-atypical-hemolytic-uremic-syndrome-ahus/">Anti–Factor H Autoantibodies and ELISA Testing: Optimizing Diagnosis in Atypical Hemolytic Uremic Syndrome (aHUS)</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Cholera and Guillain–Barré Syndrome: When Epidemics Trigger Autoimmune Neuropathy</title>
		<link>https://www.medipan.de/cholera-and-guillain-barre-syndrome-when-epidemics-trigger-autoimmune-neuropathy/</link>
		
		<dc:creator><![CDATA[Dr. Stefano Frasca]]></dc:creator>
		<pubDate>Mon, 12 Jan 2026 09:53:43 +0000</pubDate>
				<category><![CDATA[Product News]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=105722</guid>

					<description><![CDATA[<p> <img width="300" height="200" src="https://www.medipan.de/wp-content/uploads/2026/01/AdobeStock_228173499-300x200.jpeg" class="attachment-medium size-medium wp-post-image" alt="3D illustration of Vibrio cholerae bacteria in the lumen of the small intestine. The image highlights the characteristic curved, comma-shaped morphology and the single polar flagellum of the bacteria." decoding="async" loading="lazy" srcset="https://www.medipan.de/wp-content/uploads/2026/01/AdobeStock_228173499-300x200.jpeg 300w, https://www.medipan.de/wp-content/uploads/2026/01/AdobeStock_228173499-1024x683.jpeg 1024w, https://www.medipan.de/wp-content/uploads/2026/01/AdobeStock_228173499-768x512.jpeg 768w, https://www.medipan.de/wp-content/uploads/2026/01/AdobeStock_228173499-1536x1024.jpeg 1536w, https://www.medipan.de/wp-content/uploads/2026/01/AdobeStock_228173499-2048x1365.jpeg 2048w" sizes="auto, (max-width: 300px) 100vw, 300px" /> In regions affected by recurrent cholera outbreaks, overlapping infectious diseases can obscure the diagnosis of post-infectious autoimmune conditions. We recently collaborated in the publication describing a pediatric case from Yemen that illustrates how Guillain–Barré Syndrome (GBS) can emerge during a cholera outbreak, highlighting the critical role of Campylobacter jejuni infection and anti-ganglioside antibody testing 1. [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/cholera-and-guillain-barre-syndrome-when-epidemics-trigger-autoimmune-neuropathy/">Cholera and Guillain–Barré Syndrome: When Epidemics Trigger Autoimmune Neuropathy</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>2026-02 / Medipan at the WHX Labs Dubai</title>
		<link>https://www.medipan.de/2026-02-medipan-at-the-whx-labs-dubai/</link>
		
		<dc:creator><![CDATA[Augustina Bertram]]></dc:creator>
		<pubDate>Thu, 01 Jan 2026 12:24:34 +0000</pubDate>
				<category><![CDATA[Events]]></category>
		<guid isPermaLink="false">https://www.medipan.de/?p=104568</guid>

					<description><![CDATA[<p> <img width="300" height="155" src="https://www.medipan.de/wp-content/uploads/2025/09/WHX-e1758803323819-300x155.png" class="attachment-medium size-medium wp-post-image" alt="The image shows a section titled &quot;Vital stats&quot; from an event called WHX Dubai. It displays four key figures: over 235,000 professional visits, more than 4,300 exhibitors, representation from 180+ countries, and over 250 speakers. The background features a gradient from light blue to light yellow." decoding="async" loading="lazy" srcset="https://www.medipan.de/wp-content/uploads/2025/09/WHX-e1758803323819-300x155.png 300w, https://www.medipan.de/wp-content/uploads/2025/09/WHX-e1758803323819-1024x529.png 1024w, https://www.medipan.de/wp-content/uploads/2025/09/WHX-e1758803323819-768x397.png 768w, https://www.medipan.de/wp-content/uploads/2025/09/WHX-e1758803323819-1536x794.png 1536w, https://www.medipan.de/wp-content/uploads/2025/09/WHX-e1758803323819-2048x1058.png 2048w" sizes="auto, (max-width: 300px) 100vw, 300px" /> February 10 – 13, 2026 &#124; Dubai World Trade Centre &#124; Dubai, UAE Medipan at the WHX Labs Dubai 2026 formerly Medlab Middle East Medipan is proud to announce our participation in WHX Labs Dubai 2026 (formerly Medlab Middle East), one of the leading global exhibitions for laboratory diagnostics, healthcare technologies, and life sciences innovations. [&#8230;]</p>
<p>The post <a href="https://www.medipan.de/2026-02-medipan-at-the-whx-labs-dubai/">2026-02 / Medipan at the WHX Labs Dubai</a> appeared first on <a href="https://www.medipan.de">Medipan &amp; GA Generic Assays</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
